Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards

Rex JH;Pfaller MA;Galgiani JN;Bartlett MS;Espinel-Ingroff A;Ghannoum MA;Lancaster M;Odds FC;Rinaldi MG;Walsh TJ;Barry AL;;
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997 Vol. 24 pp. -
226
jh1997clinicaldevelopment

Abstract

The availability of reproducible antifungal susceptibility testing methods now permits analysis of data correlating susceptibility in vitro with outcome in vivo in order to define interpretive breakpoints. In this paper, we have examined the conceptual framework underlying interpretation of antimicr …

Keywords

National Center for Biotechnology Information NCBI NLM MEDLINE Mice review animals humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't non-p.h.s. drug resistance microbial m a pfaller antifungal agents / pharmacology* candidiasis / drug therapy* j h rex pmid:9114154 doi:10.1093/clinids/24.2.235 a l barry fluconazole / pharmacology* itraconazole / pharmacology* microbial sensitivity tests*

Access

URL:
http://www.ncbi.nlm.nih.gov/pubmed/9114154

Citation

ID: 265909
Ref Key: jh1997clinicaldevelopment
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
265909
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store